Stenson M - Search Results

1

Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy.

Gupta M, Han JJ, Stenson M, Wellik L, Witzig TE. Gupta M, et al. Among authors: stenson m. Leukemia. 2012 Jun;26(6):1356-64. doi: 10.1038/leu.2011.340. Epub 2011 Nov 25. Leukemia. 2012. PMID: 22116549 Free PMC article.

2

Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: comparison with the bromodeoxyuridine labeling index.

Beauregard P, Witzig TE, Kurtin PJ, Greipp PR, Stenson MJ, Katzmann JA, Habermann TM, Wieand HS. Beauregard P, et al. Among authors: stenson mj. Hematol Pathol. 1991;5(4):177-83. Hematol Pathol. 1991. PMID: 1794967

3

Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method.

Witzig TE, Banks PM, Stenson MJ, Griepp PR, Katzmann JA, Habermann TM, Colgan JP, Gonchoroff NJ. Witzig TE, et al. Among authors: stenson mj. Am J Clin Pathol. 1990 Sep;94(3):280-6. doi: 10.1093/ajcp/94.3.280. Am J Clin Pathol. 1990. PMID: 2204263

4

Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.

Witzig TE, Gonchoroff NJ, Greipp PR, Katzmann JA, Stenson MJ, Habermann TM, Colgan JP, Therneau TM, Banks PM. Witzig TE, et al. Among authors: stenson mj. Am J Clin Pathol. 1989 Mar;91(3):298-301. doi: 10.1093/ajcp/91.3.298. Am J Clin Pathol. 1989. PMID: 2646907

5

Effects of phenylacetate on cells from patients with B-chronic lymphocytic leukemia.

Call TG, Stenson MJ, Witzig TE. Call TG, et al. Among authors: stenson mj. Leuk Lymphoma. 1994 Jun;14(1-2):145-9. doi: 10.3109/10428199409049661. Leuk Lymphoma. 1994. PMID: 7920222

6

S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.

Witzig TE, Habermann TM, Kurtin PJ, Schroeder G, Stenson MJ, Greipp PR. Witzig TE, et al. Among authors: stenson mj. Cancer. 1995 Sep 15;76(6):1059-64. doi: 10.1002/1097-0142(19950915)76:6<1059::aid-cncr2820760621>3.0.co;2-e. Cancer. 1995. PMID: 8625208

7

Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia.

Witzig TE, Kimlinger T, Stenson M, Therneau T. Witzig TE, et al. Among authors: stenson m. Leuk Lymphoma. 1998 Sep;31(1-2):167-75. doi: 10.3109/10428199809057596. Leuk Lymphoma. 1998. PMID: 9720726

8

Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.

Ansell SM, Kurtin PJ, Stenson M, Habermann TM, Greipp PR, Therneau TM, Witzig TE. Ansell SM, et al. Among authors: stenson m. Leuk Lymphoma. 1999 Aug;34(5-6):529-37. doi: 10.3109/10428199909058480. Leuk Lymphoma. 1999. PMID: 10492076

9

Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.

Witzig TE, Timm M, Stenson M, Svingen PA, Kaufmann SH. Witzig TE, et al. Among authors: stenson m. Clin Cancer Res. 2000 Feb;6(2):681-92. Clin Cancer Res. 2000. PMID: 10690554

10

Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

Ansell SM, Stenson M, Habermann TM, Jelinek DF, Witzig TE. Ansell SM, et al. Among authors: stenson m. J Clin Oncol. 2001 Feb 1;19(3):720-6. doi: 10.1200/JCO.2001.19.3.720. J Clin Oncol. 2001. PMID: 11157023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters